TNFα induces rapid activation and nuclear translocation of telomerase in human lymphocytes

被引:55
作者
Akiyama, M [1 ]
Yamada, O
Hideshima, T
Yanagisawa, T
Yokoi, K
Fujisawa, K
Eto, Y
Yamada, H
Anderson, KC
机构
[1] Jikei Univ, Sch Med, Dept Pediat, Tokyo 1058461, Japan
[2] Jikei Univ, Sch Med, Dept Mol Genet, Inst DNA Med, Tokyo 1058461, Japan
[3] Tokyo Womens Med Univ, Dept Hematol, Tokyo 1628666, Japan
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA
关键词
telomerase; hTERT; nuclear translocation; TNF alpha; NF-kappa B; Akt;
D O I
10.1016/j.bbrc.2004.02.080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Maintenance of telomeres regulates chromosomal stability and cellular mitosis through a checkpoint mechanism. Continuous cell proliferation requires telomerase to maintain chromosomal stability and to counteract the cellular mitotic clock. Importantly, nuclear expression of telomerase activity is required for elongation of telomere sequences. In this study, we show that tumor necrosis factor alpha (TNFalpha) induces telomerase activity in the cytoplasm of peripheral blood lymphocytes (PBL) at 60 min, followed by translocation of activated telomerase to the nucleus at 120 min. Conversely, the phosphoinositol 3-kinase (PI3K) inhibitor wortmannin blocks TNFalpha-induced activation of telomerase, whereas the specific NF-kappaB translocation inhibitor SN-50 blocks TNFalpha-induced nuclear translocation of activated telomerase. These studies suggest that activation and nuclear translocation of telomerase are regulated by PI3K/Akt/NF-kappaB signaling pathways in PBL. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 14 条
[1]  
Akiyama M, 2003, CANCER RES, V63, P18
[2]  
Akiyama M, 2002, CANCER RES, V62, P3876
[3]  
Akiyama Masaharu, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P567, DOI 10.2174/1568011023353778
[4]   Switching and signaling at the telomere [J].
Blackburn, EH .
CELL, 2001, 106 (06) :661-673
[5]   Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy [J].
Chang, F ;
Lee, JT ;
Navolanic, PM ;
Steelman, LS ;
Shelton, JG ;
Blalock, WL ;
Franklin, RA ;
McCubrey, JA .
LEUKEMIA, 2003, 17 (03) :590-603
[6]  
Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482
[7]   Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit [J].
Kang, SS ;
Kwon, T ;
Kwon, DY ;
Do, SI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (19) :13085-13090
[8]   DNA damage transiently increases TRF2 mRNA expression and telomerase activity [J].
Klapper, W ;
Qian, W ;
Schulte, C ;
Parwaresch, R .
LEUKEMIA, 2003, 17 (10) :2007-2015
[9]   Telomerase activity and telomere length of peripheral blood mononuclear cells in SLE patients [J].
Kurosaka, D ;
Yasuda, J ;
Yoshida, K ;
Yokoyama, T ;
Ozawa, Y ;
Obayashi, Y ;
Kingetsu, I ;
Saito, S ;
Yamada, A .
LUPUS, 2003, 12 (08) :591-599
[10]   Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy? [J].
Kyo, S ;
Inoue, M .
ONCOGENE, 2002, 21 (04) :688-697